Thomas M. Moriarty - 28 Jun 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Reporting relationship: EVP & General Counsel
Issuer ticker: CVS
Reported as of: 28 Jun 2022
Net transaction value: -$4,671,733
SEC form: 4
Accepted by SEC: 30 Jun 2022, 17:00:11 UTC
Prior SEC filing: 05 Apr 2022
Next SEC filing: 16 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Thomas M. Moriarty

Key filing fact

Thomas M. Moriarty filed Form 4 for CVS HEALTH Corp (CVS) on 30 Jun 2022.

Key facts

This page summarizes Thomas M. Moriarty's Form 4 filing for CVS HEALTH Corp (CVS).
9 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 30 Jun 2022, 17:00.

Change

Previous filing in this sequence was filed on 05 Apr 2022.
Current net transaction value: -$4,671,733.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVS transaction

Common Stock

Options Exercise

Transaction value: $2,875,430
Shares: +49,279
Change %: +7.9%
Price: $58.35
Shares after: 675,552
Date: 28 Jun 2022
Ownership: Direct

CVS transaction

Common Stock

Sale

Transaction value: $4,681,505
Shares: -49,279
Change %: -7.3%
Price: $95.00
Shares after: 626,273
Date: 28 Jun 2022
Ownership: Direct
Footnotes: F1

CVS transaction

Common Stock

Options Exercise

Transaction value: $2,736,703
Shares: +50,502
Change %: +8.1%
Price: $54.19
Shares after: 676,775
Date: 28 Jun 2022
Ownership: Direct

CVS transaction

Common Stock

Sale

Transaction value: $4,797,690
Shares: -50,502
Change %: -7.5%
Price: $95.00
Shares after: 626,273
Date: 28 Jun 2022
Ownership: Direct
Footnotes: F1

CVS transaction

Common Stock

Options Exercise

Transaction value: $2,888,264
Shares: +38,873
Change %: +6.2%
Price: $74.30
Shares after: 665,146
Date: 28 Jun 2022
Ownership: Direct

CVS transaction

Common Stock

Sale

Transaction value: $3,692,935
Shares: -38,873
Change %: -5.8%
Price: $95.00
Shares after: 626,273
Date: 28 Jun 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVS transaction Derivative

Stock Option

Options Exercise

Transaction value: $0
Shares: -49,279
Change %: -33%
Price: $0.000000
Shares after: 98,558
Date: 28 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 49,279
Exercise price: $58.34
Footnotes: F2, F3

CVS transaction Derivative

Stock Option

Options Exercise

Transaction value: $0
Shares: -50,502
Change %: -50%
Price: $0.000000
Shares after: 50,502
Date: 28 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,502
Exercise price: $54.19
Footnotes: F4

CVS transaction Derivative

Stock Option

Options Exercise

Transaction value: $0
Shares: -38,873
Change %: -25%
Price: $0.000000
Shares after: 116,622
Date: 28 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 38,873
Exercise price: $74.30
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

All sales were effected pursuant to a Rule 10b5-1 plan.

Footnote F2

The number of shares subject to the option were calculated using a 30-day average price.

Footnote F3

Option became exercisable in four equal annual installments, commencing 4/1/2021.

Footnote F4

Option became exercisable in four equal annual installments, commencing 4/1/2020.

Footnote F5

Option became exercisable in four equal annual installments, commencing 4/1/2022.